Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124278) titled 'Cetuximab ß combined with Envafolimab, Suvemcitug and chemotherapy for neoadjuvant treatment of penile cancer' on May 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Langfang Campus of Chinese Academy of Medical Sciences Cancer Hospital
Condition:
Stage IB-IV penile cancer
Intervention:
Group B- control group:Paclitaxel Polymer Micelles for Injection + Cisplatin + Ifosfamide
Group B- experimental group:Paclitaxel Polymer Micelles for Injection + Cisplatin + Ifosfamide + Suvemcitug + Envafolimab + Cetuximab ß
Recruitment Status: Not Recruiting
Phase: 4
Date of First...